• Home
• Key Data
• Bayer Stock
• Management Report
  • Overview of Sales, Earnings and Financial Position
  • Economic Outlook
  • Sales and Earnings Forecast
  • Corporate Structure
  • Performance by Subgroup, Segment and Region
    • HealthCare
    • CropScience
    • MaterialScience
    • Performance by Region
  • Calculation of EBIT(DA) Before Special Items
  • Core Earnings Per Share
  • Financial Position of the Bayer Group
  • Employees
  • Opportunities and Risks
  • Events After the Reporting Period
• Financial Statements
  • Income Statements
  • Comprehensive Income
  • Financial Position
  • Statements of Cash Flows
  • Changes in Equity
  • Notes to the Condensed Consolidated Interim Financial Statements
    • Key Data by Segment
    • Key Data by Region
    • Explanatory Notes
• Focus
• News
  • Overview
  • Better treatment for MS patients in China
  • Otto Bayer Medals awarded to top researchers
  • Good news on rivaroxaban from Bayer
  • Increasing oil content and combating disease in oilseed
  • Entering the aesthetic medicine segment
  • Collaboration on energy-efficient buildings
  • Using carbon dioxide as a raw material
  • Orodispersible tablet to treat erectile dysfunction
  • Milestone registration expands product portfolio for cereals
  • New pioneering active ingredient to combat weeds
  • Expansion of research on vegetable seed varieties
  • 14-year-old Chinese girl wins painting competition organized by UNEP and Bayer
  • Confirmation of successful climate strategy
• Services
  • Overview
  • Download Center

Print Page

Download Center

Links

Publications

Services

Special Interest

• Investor Relations
• Press
• Jobs and Career
• Foundations
• Culture

• General Conditions of Use
• Privacy Statement
• Imprint
• Technical Details